<table id="ibc1603b8-6a48-467b-81c5-35926afa9295" width="673" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>
                TABLE IV Lipid-lowering Effects of Lovastatin in Adolescent Boys with
                Heterozygous Familial Hypercholesterolemia (Mean Percent Change from Baseline at
                week 48 in Intention-to-Treat Population)
              </caption>
<col align="left" valign="bottom" width="18%"></col>
<col align="center" valign="bottom" width="17%"></col>
<col align="center" valign="bottom" width="17%"></col>
<col align="center" valign="bottom" width="17%"></col>
<col align="center" valign="bottom" width="17%"></col>
<col align="center" valign="bottom" width="17%"></col>
<col align="center" valign="bottom" width="18%"></col>
<thead>
<tr>
<th>DOSAGE</th>
<th>N</th>
<th>TOTAL-C</th>
<th>LDL-C</th>
<th>HDL-C</th>
<th>
                    TG. *
                  </th>
<th>Apolipoprotein B</th>
</tr>
</thead>
<tbody>
<tr>
<td>Placebo</td>
<td>61</td>
<td>–1.1</td>
<td>–1.4</td>
<td>–2.2</td>
<td>–1.4</td>
<td>–4.4</td>
</tr>
<tr>
<td>Lovastatin</td>
<td>64</td>
<td>–19.3</td>
<td>–24.2</td>
<td>+1.1</td>
<td>–1.9</td>
<td>–21</td>
</tr>
</tbody>
</table>